Hematology/Oncology News

People with cancer had more than double the risk for COVID-19 mortality than the general population, according to study results.

Women with breast cancer who began an aerobic exercise program at the start of chemotherapy self-reported improved cognitive function and quality of life, according to results of a randomized trial.

A high percentage of childhood survivors do not undergo guideline-recommended monitoring for late effects, according to results of a population-based study.

Technologic advances such as online patient portals have given patients unprecedented access to their health care providers.

CHICAGO — Patients treated with mirvetuximab require close follow-up with an ophthalmologist due to the potential for corneal toxicity, according to a study.

The addition of immune checkpoint inhibitor therapy to neoadjuvant chemotherapy improved pathologic complete response and EFS for certain patients with early-stage breast cancer, according to a systematic review and meta-analysis.

The FDA approved Vyloy with chemotherapy to treat locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma in adults, according to a press release.

Gilead Sciences announced its intention to voluntarily withdraw the accelerated approval for sacituzumab govitecan-hziv for treatment of certain patients with advanced bladder cancer.

ORLANDO — A skin cancer diagnosis can be very overwhelming for a patient. Sharing informative materials about treatment options may ease their minds, according to a speaker at the American Society for Dermatologic Surgery Annual Meeting.

Adjuvant durvalumab significantly improved PFS and OS compared with placebo among patients with limited-stage small cell lung cancer, according to study results presented at ESMO Congress.